News and Events

DDReg is thrilled to announce that it has made it as a finalist for the CPHI Pharma Awards 2023. With 12 categories and 180 submissions, DDReg was shortlisted under the ‘Regulatory’ category for its entry on Technology-Enabled Regulatory Services through Vitalic®.  Indeed, this is a testament to DDReg’s commitment  towards regulatory excellence and innovation. Read about …

DDReg Shortlisted for ‘Regulatory’ by CPHI Pharma Awards 2023 Read More »

DDReg took a significant stride toward nurturing its team’s potential by partnering with Oktane HR. Following the success of the ‘High Impact Manager Program’ held earlier, in June, DDReg & Oktane HR partnered once again to elevate the leadership and growth capabilities. This session was carefully curated for the next in-lines and was led by …

DDREG & OKTANE HR – Training and Development Program for Employees Read More »

The DIA Global Annual Meeting in 2023, which took place in Boston, United States, was a remarkable event that brought together stakeholders from various sectors, including industry, regulatory bodies, government agencies, academia, and most importantly, patients.One of the key highlights of the DIA 2023 conference was the emphasis on the latest innovations in clinical development. …

DDReg Exhibits at DIA Global 2023 Read More »

DDReg places a strong emphasis on continuously nurturing and expanding its leadership team to drive long-term organizational success. In line with this vision, DDReg was fortunate to have been supported by Oktane HR- a leadership and growth focussed consultancy that is dedicated to refining leadership capabilities and learning. Principal consultant, Mr. Sunil Bhardwaj, and Lead …

DDReg & Oktane HR – “High Impact Manager Program” Read More »

End to end global regulatory services driven through technology-enabled solutions.DDReg featured in BioPharma Dive, a leading Pharmaceutical Industry publication that provides insight into emerging trends and news that are driving the Industry. Among these trends is outsourcing regulatory affairs that have brought substantial value to the business by saving cost & resources, de-risking other business …

DDReg features in BioPharma Dive Read More »

The European Union has seen some major changes and advances in Regulatory & Healthcare Policies and strategies- a key one being the “Regulatory Science to 2025” strategy to enhance EMA’s engagement with regulatory science. The need for proactive participation in such initiatives is important to support the strengthening of regulatory systems and facilitate innovation in …

DDReg Exhibits at DIA Europe 2023 in Basel, Switzerland Read More »

We are exhibiting at DIA Europe 2023 Meet our experts at booth #59 to discuss your queries on market access strategies , Regulatory Intelligence, Regulatory Strategies, Feasibility Studies, Life Cycle Management. Run your regulatory processes with our technology enabled platforms that help generate better data, for faster market access, safety and efficacy of vital, life-altering …

We are exhibiting at DIA Europe 2023 Read More »

Ever since the incorporation, it has been DDReg’s endeavor to provide high quality services to its customers. To achieve this, DDReg has been consistently and regularly working towards improving its quality standards. For more than 6 years now, we have been achieving the high-quality standards set up by ISO 9001:2015, through the global accreditation agency …

DDReg receives the ISO 27001:2013 certification for Information Security Management System Read More »

On Friday 1st July 2022, DDReg Pharma wholeheartedly celebrated its 13th Foundation Day. Employees from the Gurgaon, Mumbai, and Hyderabad offices connected virtually to commemorate not only the grand occasion but also each other’s milestones and achievements. The day consisted of fun activities including interactive games and performances by employees such as singing, instruments, poetry, …

DDReg celebrates its 13th Foundation Day Read More »

Drug abuse has gradually become an increasing issue due to the use of non-medical prescription drugs. Thus, pharmacovigilance and drug safety has become an even more crucial aspect for ensuring patient safety by monitoring adverse drug reactions and evaluating the safe use of medicines. To do this, robust procedures must be established while keeping in …

DDReg attends National Conference on Pharmacovigilance and Clinical Research 2022- Chandigarh College of Pharmacy Read More »